News
Respiratory symptoms send millions of people to emergency departments (EDs) every year. For clinicians, sorting through those symptoms quickly isn’t easy. For patients, that uncertainty can be stressful: long waits, unclear answers, and sometimes unnecessary treatments, including antibiotics that won’t help viral infections.
Swipe to discover more
-
bioMérieux – 2025 Financial Results
Consolidated sales amounted to €4,070 million in 2025, up 6.2% like-for-like from €3,980 million in the prior year period. Reported growth stood at +2.3% for the period. -
Always consider sepsis in the context of infection.
Patient associations across the globe are actively engaged in promoting this critical message to both healthcare professionals and the broader public. We met with Dr Rafael Moraes from ILAS, Melissa Mead from The UK Sepsis Trust and Thomas Heymann from Sepsis Alliance to learn more about their actions. -
Rising to the Challenge: Harnessing Diagnostics to Combat Infectious Diseases and AMR
Global health leaders unite to unlock the value of diagnostics in the fight against antimicrobial resistance.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19